Pharmacoeconomic analysis of everolimus immunosuppressive therapy for <i>de novo</i> kidney transplant recipients in Russia

Currently, patients after kidney transplantation can receive mycophenolate mofetil (MPM), mycophenolic acid (MPA), cyclosporine (CSA) and tacrolimus (TAC) through the Federal High-cost Nosologies Program (VZN) in Russia. Use of everolimus (EVL) in combination with a reduced dose of calcineurin inhib...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	N. A. Avxentyev, E. V. Derkach, E. I. Prokopenko
פורמט:	Artigo
שפה:	Russo
יצא לאור:	Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2019-05-01
סדרה:	Вестник трансплантологии и искусственных органов
נושאים:	kidney transplantation immunosuppressive therapy everolimus mycophenolic acid cyclosporine tacrolimus cost minimization budget impact analysis
גישה מקוונת:	https://journal.transpl.ru/vtio/article/view/986
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!